Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 299, pseudogene (RN7SL299P)

Target
RN7SL299P
Molecular classification
Other (non-coding RNA pseudogene)
01

Overview

RN7SL299P is a truncated copy of the 7SL RNA gene, categorized as a pseudogene dispersed in the human genome, resulting from reverse transcription of 7SL RNA back into DNA[5][6]. Most 7SL RNA-like sequences in human DNA are pseudogenes, not functional genes; only a handful genuinely encode the signal recognition particle RNA required for co-translational protein targeting[5][6]. RN7SL299P itself does not produce functional RNA or protein, does not participate in signal transduction, cell cycle control, or other biological processes, and is not recognized as a molecular target in therapeutic or pharmacological contexts[1][5][6]. There is no evidence suggesting RN7SL299P is involved in disease, modulates pathology, or is utilized as a biomarker. If a therapeutic or functional role is required, refer to the authentic 7SL RNA gene (not pseudogenes like RN7SL299P)[3][4]. In summary: RN7SL299P is an annotated genomic pseudogene with no known biological, therapeutic, or diagnostic relevance. It is not a receptor, enzyme, transporter, or recognized drug target, and its presence in the genome is largely attributed to retrotransposition events from 7SL RNA[5][6].

Other names
RN7SL299P7SL RNA pseudogeneRNA, 7SL, cytoplasmic 299, pseudogene

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 299, pseudogene (RN7SL299P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 299, pseudogene (RN7SL299P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call